Ipillimumab promotes tumour control and survival advantage in patients with advanced melanoma with or without immune-related undesired effects (irAEs) Journal Article


Authors: Lutzky, J.; Hauschild, A.; Wolchok, J.; Hamid, O.; Lebbé, C.; Pehamberger, H.; Linette, G.; de Pril, V.; Ibrahim, R.; Hoos, A.; O'Day, S.
Article Title: Ipillimumab promotes tumour control and survival advantage in patients with advanced melanoma with or without immune-related undesired effects (irAEs)
Journal Title: Journal Der Deutschen Dermatologischen Gesellschaft
Volume: 7
Issue: 9
ISSN: 1610-0379
Publisher: Wiley Blackwell  
Date Published: 2009-01-01
Start Page: 835
End Page: 836
Language: German
ACCESSION: ISI:000269371500047
PROVIDER: wos
Notes: --- - Meeting Abstract - "Source: Wos"
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok